Bortezomib Induced Tumor Lysis Syndrome in Multiple Myeloma
Shinae YU; Sung-Woo RYU; Kyoung-Ha KIM; Se-Hyoung KIM; Nam-Su LEE; Sung-Kyu PARK; Jong-Ho WON.
Soonchunhyang Medical Science
; : 31-33, 2013.
Artículo en Inglés | WPRIM | ID: wpr-8456
Documentos relacionados
Plasmacytoma-like post-transplant lymphoproliferative disorder seen in pediatric combined liver and intestinal transplant recipients.
SLAM family receptors and SAP adaptors in immunity.
A personalized approach to lymphoproliferations in patients with inborn errors of immunity.
SNS01-T modulation of eIF5A inhibits B-cell cancer progression and synergizes with bortezomib and lenalidomide.
Preemptive hematopoietic cell transplantation for asymptomatic patients with X-linked lymphoproliferative syndrome type 1.
Ocular lymphoproliferative disorders.
Ulcerating Esophageal Lesions.
A Case-Based Review of Cutaneous CD30-Positive Lymphoproliferative Disorders.
Methodological and conceptual challenges to the flow cytometric classification of leukemic lymphoproliferative disorders.
Hydroa Vacciniforme Lymphoproliferative Disorder in a Young Spanish Woman: An Infrequent Case With Fatal Outcome.